Stephan G Thompson

Title: Innovations by Stephan G. Thompson: Pioneering Immunogenic Research

Introduction

Stephan G. Thompson, based in South Bend, Indiana, is an accomplished inventor with a focus on immunogenic research. With two patents to his name, he has made significant contributions to the field of antibodies and their applications in immunoassays. His work is particularly notable for addressing the measurement of lidocaine and disopyramide in biological fluids, offering valuable tools for healthcare and medical diagnostics.

Latest Patents

Thompson's most recent patents include innovations centered around immunogens and antibodies for the drug lidocaine. One patent details the preparation of antibodies against lidocaine and related compounds, utilizing immunogens that comprise lidocaine or its analogs coupled to a conventional immunogenic carrier. These antibodies and labeled conjugates facilitate homogeneous nonradioisotopic immunoassays, enabling accurate measurement of lidocaine in serum and other biological fluids.

The second patent focuses on disopyramide, elaborating on immunogens and antibodies tailored for this medication. The immunogens involve disopyramide coupled by an ether linkage at a specific position on its phenyl ring, offering a pathway to create antibodies and labeled conjugates for similar immunoassay applications. These advancements showcase Thompson's dedication to improving diagnostic processes through innovative methodologies.

Career Highlights

Throughout his career at Miles Laboratories, Inc., Thompson has developed a reputation for his groundbreaking research in immunogen development. His dual patents highlight both his technical expertise and commitment to enhancing healthcare diagnostics. By focusing on the creation of synthetic intermediates and their applications in immunoassays, Thompson has reinforced the importance of accurate drug measurement in clinical settings.

Collaborations

In his endeavors, Thompson has worked alongside notable colleagues, including Robert T. Buckler and John F. Burd. Their collaborative efforts have contributed to the successful development of his patents, fostering a shared commitment to innovation in the biomedical field.

Conclusion

Stephan G. Thompson's contributions to immunogenic research exemplify the spirit of innovation that drives advancements in medical diagnostics. With his patents addressing critical healthcare needs, he stands as a prominent figure in the realm of antibody development and immunoassays. His work not only exemplifies ingenuity but also paves the way for future innovations in the biopharmaceutical sector.